Evaluation of Ketamine's Impact on Vasopressor Requirements in Critically Ill Patients: A Retrospective Cohort Study [0.03%]
评估氯胺酮对重症患者血管加压药物需求影响的回顾性队列研究
Noah Gann,Patrick Ratliff,Avery Guerrero et al.
Noah Gann et al.
Background: Ketamine is a commonly used sedative agent for procedural sedation and rapid sequence intubation. Ketamine can also be administered via continuous infusion as an adjunct agent for sedation and analgesia in mec...
Risk Factors Associated with Thrombus Development Following Pharmacologic Anticoagulation Reversal with Coagulation Factor Xa [Recombinant], Inactivated-zhzo [0.03%]
逆转抗凝的凝血因子Xa（重组），灭活后血栓形成的危险因素相关性研究
David Zingale,Raymond Lamore,Derek Peiffer et al.
David Zingale et al.
Background: Andexanet alfa (AA), a recombinant coagulation factor Xa, is approved as an antidote for the treatment of bleeding secondary to rivaroxaban and apixaban. While thromboembolism may serve as a risk with reversal...
Association Between Irbesartan and Erectile Dysfunction: A Comprehensive Analysis Incorporating Real-World Pharmacovigilance and Mendelian Randomization [0.03%]
伊贝沙坦与勃起功能障碍之间的关联：全面分析真实世界药物警戒和孟德尔随机化研究结果
Kaiqin Chen,Rui Cheng,Jian Guo et al.
Kaiqin Chen et al.
Background: Irbesartan is widely used for hypertension management, but its relationship with erectile dysfunction (ED) is unclear. This study combines real-world data from the FAERS database with Mendelian randomization to explore this pote...
Based on the FDA Adverse Event Reporting System Database, a Study on Signal Mining of Adverse Events for Guanylate Cyclase-C Receptor Agonists [0.03%]
基于FDA不良事件报告系统数据库的鸟苷酸环化酶-C受体激动剂类药物不良事件信号挖掘研究
Da Lei,Chiwei Guo,Shujuan Zhao
Da Lei
Objective: To analyze and evaluate adverse drug event (ADE) signals for two GC-C receptor agonists, Linaclotide and Plecanatide, thereby enhancing understanding of their clinical safety. ...
Assessment of Meropenem Stability in Meropenem Admixtures Using 2 g Vials and Normal Saline Prepared Using addEASE® Connectors [0.03%]
评估使用2克小瓶和生理盐水制备的美罗培南添加剂中美罗培南稳定性
Christian M Gill,Teresa Sierra,Nicholas Kovarik et al.
Christian M Gill et al.
Background: Pharmacokinetic and pharmacodynamic optimization of β-lactams, including meropenem, using extended infusion are recommended by contemporary guidance to overcome elevated MICs and high interpatient pharmacokin...
Letter to the Editor: The Pharmacological Responsibility Chain - Mapping Competence Toward Responsible Prescribing [0.03%]
致编辑的信：药学责任链——面向负责任处方的能力图谱
Almir Fajkić,Andrej Belančić,Dinko Vitezić
Almir Fajkić
Letter to the Editor: Lean-Body Mass-Guided Heparin Dosing: A Pharmacokinetic Imperative [0.03%]
论著来信：Lean Body Mass指导的肝素用药： pharmacokinetic决定因素？
Andrej Belančić,Almir Fajkić,Hesham Al-Sallami
Andrej Belančić
Huynh Tran Bao Chau,Hoang Bao Tran Van,Can Nguyen Thi et al.
Huynh Tran Bao Chau et al.
Letter to the Editor: Unlocking Antibiotic Stewardship Potential Through Penicillin Allergy De-labelling [0.03%]
论著来信：通过去除青霉素过敏标签发挥抗生素管理的潜力
Andrej Belančić,Iva Mikulić,Robert Likić
Andrej Belančić
Missed Doses, Missed Opportunities: Readmission Due to GLP-1RA Interruption Inspires Algorithms to Improve Reinitiation of Therapy at Discharge [0.03%]
错失的剂量，错失的机会：因GLP-1受体激动剂治疗中断而导致的再入院促使人们在出院时制定算法以改善治疗重启
Adrienne Michelet,Maksudul Mowla,Baaba A Amo-Brown et al.
Adrienne Michelet et al.
Objectives: The objectives of this case report are to describe the hospitalization of a patient due to a preventable adverse event caused by dulaglutide after restarting therapy following a previous hospitalization where ...